androstenediol has been researched along with bilirubin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Jackson, WE; McKinney, L; Miner, V; Seed, TM; Whitnall, MH; Wilhelmsen, CL | 1 |
1 review(s) available for androstenediol and bilirubin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 other study(ies) available for androstenediol and bilirubin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Radioprotective efficacy and acute toxicity of 5-androstenediol after subcutaneous or oral administration in mice.
Topics: Administration, Oral; Alkaline Phosphatase; Androstenediol; Animals; Bilirubin; Body Weight; Female; Injections, Subcutaneous; Lipase; Mice; Mice, Inbred C3H; Radiation-Protective Agents | 2002 |